168 related articles for article (PubMed ID: 25481789)
1. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.
Kong W; Jarvis C; Mackillop WJ
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):83-91. PubMed ID: 25481789
[TBL] [Abstract][Full Text] [Related]
2. Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.
Mackillop WJ; Kong W
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):51-59. PubMed ID: 26700702
[TBL] [Abstract][Full Text] [Related]
3. Estimating the need for palliative radiotherapy for non-small cell lung cancer: A criterion-based benchmarking approach.
Jin CJ; Kong W; Mackillop WJ
Radiother Oncol; 2018 Sep; 128(3):541-547. PubMed ID: 29934108
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the use of palliative radiotherapy in Ontario.
Huang J; Zhou S; Groome P; Tyldesley S; Zhang-Solomans J; Mackillop WJ
J Clin Oncol; 2001 Jan; 19(1):137-44. PubMed ID: 11134206
[TBL] [Abstract][Full Text] [Related]
5. Palliative radiotherapy for women with breast cancer.
Danielson B; Winget M; Gao Z; Murray B; Pearcey R
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):506-12. PubMed ID: 18524556
[TBL] [Abstract][Full Text] [Related]
6. Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):481-9. PubMed ID: 17467249
[TBL] [Abstract][Full Text] [Related]
7. Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach.
Barbera L; Zhang-Salomons J; Huang J; Tyldesley S; Mackillop W
Med Care; 2003 Sep; 41(9):1074-85. PubMed ID: 12972847
[TBL] [Abstract][Full Text] [Related]
8. The use of palliative whole brain radiotherapy in the management of brain metastases.
Kong W; Jarvis CR; Sutton DS; Ding K; Mackillop WJ
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e149-58. PubMed ID: 23063070
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of the fractionation of palliative radiotherapy for bone metastasis in Ontario.
Kong W; Zhang-Salomons J; Hanna TP; Mackillop WJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1209-17. PubMed ID: 17967310
[TBL] [Abstract][Full Text] [Related]
10. Survival after palliative radiotherapy in geriatric cancer patients.
Nieder C; Angelo K; Haukland E; Pawinski A
Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
[TBL] [Abstract][Full Text] [Related]
11. A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in ontario.
Mackillop WJ; Kong W; Brundage M; Hanna TP; Zhang-Salomons J; McLaughlin PY; Tyldesley S
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1099-107. PubMed ID: 25832700
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing access to palliative radiotherapy: a Norwegian population-based study.
Åsli LM; Myklebust TÅ; Kvaløy SO; Jetne V; Møller B; Levernes SG; Johannesen TB
Acta Oncol; 2018 Sep; 57(9):1250-1258. PubMed ID: 29706109
[TBL] [Abstract][Full Text] [Related]
13. Estimating need for palliative external beam radiotherapy in adult cancer patients.
Nieder C; Pawinski A; Haukland E; Dokmo R; Phillipi I; Dalhaug A
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):207-11. PubMed ID: 19362788
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.
Angelo K; Norum J; Dalhaug A; Pawinski A; Aandahl G; Haukland E; Engljähringer K; Nieder C
Anticancer Res; 2014 Feb; 34(2):877-85. PubMed ID: 24511026
[TBL] [Abstract][Full Text] [Related]
15. Preventing Discontinuation of Radiation Therapy: Predictive Factors to Improve Patient Selection for Palliative Treatment.
Puckett LL; Luitweiler E; Potters L; Teckie S
J Oncol Pract; 2017 Sep; 13(9):e782-e791. PubMed ID: 28759295
[TBL] [Abstract][Full Text] [Related]
16. Collaborating with the Community: Improving Patient Access to Palliative Radiation Therapy.
Loudon J; Rozanec N; Clement A; Woo R; Grant A; Murray J; Wells W
Pract Radiat Oncol; 2020; 10(1):1-7. PubMed ID: 31437605
[TBL] [Abstract][Full Text] [Related]
17. Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):801-9. PubMed ID: 20797840
[TBL] [Abstract][Full Text] [Related]
18. Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study.
Huang J; Wai ES; Lau F; Blood PA
BMC Palliat Care; 2014; 13(1):49. PubMed ID: 25419181
[TBL] [Abstract][Full Text] [Related]
19. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study.
Lavergne MR; Johnston GM; Gao J; Dummer TJ; Rheaume DE
Palliat Med; 2011 Mar; 25(2):101-10. PubMed ID: 20937613
[TBL] [Abstract][Full Text] [Related]
20. Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance.
Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
Int J Circumpolar Health; 2017; 76(1):1270080. PubMed ID: 28452680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
